Webinar recording on PIK3CA mutation testing

Webinar recording

PIK3CA mutation testing

Watch now: Testing for PIK3CA mutations in advanced or metastatic breast cancer

Dr. Lawrence Weiss, Chief Medical Officer at NeoGenomics discusses implementation of the therascreen PIK3CA RGQ PCR Kit for testing of tissue and plasma samples in advanced or metastatic breast cancer. His presentation includes:

An overview of HR+/HER2– breast cancer progression and resistance to endocrine therapy
The biology and activation of the PI3K pathway, and its role in cancer
Validation and implementation of the therascreen PIK3CA RGQ PCR Kit for testing of both FFPE tissue and plasma samples
The provision of Day 1 availability of PIK3CA mutation companion diagnostic testing

An FDA-approved companion diagnostic test, the therascreen PIK3CA RGQ PCR Kit helps clinicians identify actionable PIK3CA mutations in breast cancer cases, to inform patient treatment choices.

Learn more about the therascreen PIK3CA RGQ PCR Kit

Fill out the form to watch the webinar

Address1

hiddenWithCSS

First Name*

Last Name*

Work Email*

Work Phone

Organization*

Job Position*

Country*

State or Province

Required only for USA & Canada || Require when country contains USA or Canada

I want to be the first to hear about offers and news from QIAGEN*

* Required fields

By checking the box above, you submit your information to QIAGEN, who will use it to communicate with you regarding this topic. QIAGEN may also use your personal information for internal business and marketing purposes, including but not limited to webinar and raffle registration, product, trial, educational and events information. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) and our commercial partners solely for the purposes of data hosting, phone calls and QIAGEN email distribution. You may unsubscribe at any time. If you withdraw your consent we will not be able to communicate with you on this topic. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation. For further details please refer to our Privacy Policy.

The therascreen PIK3CA RGQ PCR Kit is intended for in vitro diagnostic use. Products and product claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.